ACRS logo

Aclaris Therapeutics (ACRS) Net Income

Annual Net Income

-$88.48 M
-$1.57 M-1.81%

December 31, 2023

Summary

Performance

1-Year Change

-1.81%

3-Year Change

-73.44%

5-Year Change

+33.34%

15-Year Change

-29.13%

ACRS Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

24.02%
ACRS annual net profit is higher than 24.02% of companies in Healthcare sector

High & Low

All-time High

-$5.24 M

3-Year Low

-$90.86 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ACRS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 27, 2025
ACRS next annual earnings announcement is scheduled for Feb 27, 2025

OtherACRSprofitabilitymetrics:

Annual Net Margin

-283.15%
ACRS annual net profit margin is -283.15%

Annual Revenue

$31.25 M
ACRS annual revenue is $31.25 million

Annual Gross Profit

$13.17 M
ACRS annual gross profit is $13.17 million

Annual EPS

-$1.27
ACRS annual earnings per share is -$1.27

Quarterly Net Income

-$7.59 M
+$3.40 M+30.95%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+74.07%

3-Year Change

+64.13%

5-Year Change

+86.29%

ACRS Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.75%
ACRS quarterly net profit is higher than 45.75% of companies in Healthcare sector

High & Low

All-time High

-$1.49 M

3-Year Low

-$29.57 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ACRS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 27, 2025
ACRS next earnings announcement is scheduled for Feb 27, 2025

OtherACRSprofitabilitymetrics:

Quarterly Net Margin

-174.55%
ACRS quarterly net profit margin is -174.55%

Quarterly Revenue

$4.35 M
ACRS quarterly revenue is $4.35 million

Quarterly Gross Profit

$1.94 M
ACRS quarterly gross profit is $1.94 million

Quarterly EPS

-$0.11
ACRS quarterly earnings per share is -$0.11

TTM Net Income

-$37.00 M
+$21.68 M+36.94%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+67.72%

3-Year Change

+54.45%

5-Year Change

+73.45%

ACRS TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.4%
ACRS TTM net profit is higher than 44.4% of companies in Healthcare sector

High & Low

All-time High

-$2.66 M

3-Year Low

-$114.63 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ACRS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 27, 2025
ACRS next earnings announcement is scheduled for Feb 27, 2025

OtherACRSprofitabilitymetrics:

Annual Net Margin

-283.15%
ACRS annual net profit margin is -283.15%

TTM Revenue

$27.08 M
ACRS TTM revenue is $27.08 million

TTM Gross Profit

$14.49 M
ACRS TTM gross profit is $14.49 million

TTM EPS

-$0.52
ACRS TTM earnings per share is -$0.52

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$88.48 M
ACRS annual net profit is -$88.48 million

Annual Revenue

$31.25 M
ACRS annual revenue is $31.25 million

Annual Cost Of Goods Sold

$18.08 M
ACRS annual cost of goods sold is $18.08 million

Annual Operating Expenses

$129.48 M
ACRS annual total operating expenses is $129.48 million

Annual Interest Expense

-
ACRS annual interest expense value is unknown

Annual Income Tax

-$367.00 K
ACRS annual income tax is -$367.00 thousand

ACRS Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1.8%+74.1%+67.7%
3 y3 years-73.4%+64.1%+54.5%
5 y5 years+33.3%+86.3%+73.5%

ACRS Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1.8%+2.6%-408.8%+74.3%at high+67.7%
5 y5-year-73.4%+45.2%-408.8%+74.3%at high+77.1%
alltimeall time-1589.9%+45.2%-408.8%+86.3%-1292.7%+79.6%

Aclaris Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$7.59 M(-30.9%)
-$37.00 M(-36.9%)
Jun 2024
-
-$10.99 M(-35.2%)
-$58.68 M(-24.1%)
Mar 2024
-
-$16.94 M(+1036.2%)
-$77.26 M(-12.7%)
Dec 2023
-$88.48 M(+1.8%)
-$1.49 M(-94.9%)
-$88.48 M(-22.8%)
Sep 2023
-
-$29.26 M(-1.0%)
-$114.63 M(+8.8%)
Jun 2023
-
-$29.57 M(+5.0%)
-$105.32 M(+9.4%)
Mar 2023
-
-$28.16 M(+1.9%)
-$96.28 M(+10.8%)
Dec 2022
-$86.91 M(-4.4%)
-$27.64 M(+38.5%)
-$86.91 M(+5.9%)
Sep 2022
-
-$19.95 M(-2.8%)
-$82.08 M(-1.4%)
Jun 2022
-
-$20.53 M(+9.3%)
-$83.27 M(+2.9%)
Mar 2022
-
-$18.79 M(-17.6%)
-$80.90 M(-11.0%)
Dec 2021
-$90.86 M(+78.1%)
-$22.80 M(+7.8%)
-$90.86 M(+11.9%)
Sep 2021
-
-$21.15 M(+16.4%)
-$81.23 M(+14.8%)
Jun 2021
-
-$18.16 M(-36.8%)
-$70.75 M(+10.2%)
Mar 2021
-
-$28.75 M(+118.3%)
-$64.18 M(+25.8%)
Dec 2020
-$51.02 M(-68.4%)
-$13.17 M(+23.6%)
-$51.02 M(-9.6%)
Sep 2020
-
-$10.66 M(-8.1%)
-$56.44 M(-44.2%)
Jun 2020
-
-$11.60 M(-25.6%)
-$101.10 M(-27.5%)
Mar 2020
-
-$15.59 M(-16.2%)
-$139.38 M(-13.6%)
Dec 2019
-$161.35 M
-$18.59 M(-66.4%)
-$161.35 M(-11.0%)
Sep 2019
-
-$55.32 M(+10.9%)
-$181.31 M(+14.2%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$49.88 M(+32.8%)
-$158.73 M(+13.3%)
Mar 2019
-
-$37.56 M(-2.6%)
-$140.07 M(+5.5%)
Dec 2018
-$132.74 M(+93.7%)
-$38.55 M(+17.7%)
-$132.74 M(+13.3%)
Sep 2018
-
-$32.74 M(+4.9%)
-$117.12 M(+14.2%)
Jun 2018
-
-$31.22 M(+3.3%)
-$102.57 M(+19.0%)
Mar 2018
-
-$30.23 M(+31.8%)
-$86.19 M(+25.8%)
Dec 2017
-$68.52 M(+42.5%)
-$22.93 M(+26.1%)
-$68.52 M(+20.1%)
Sep 2017
-
-$18.19 M(+22.6%)
-$57.06 M(+15.1%)
Jun 2017
-
-$14.84 M(+18.1%)
-$49.57 M(+4.1%)
Mar 2017
-
-$12.56 M(+9.4%)
-$47.60 M(-1.0%)
Dec 2016
-$48.08 M(+133.8%)
-$11.47 M(+7.3%)
-$48.08 M(+16.4%)
Sep 2016
-
-$10.69 M(-16.9%)
-$41.32 M(+0.2%)
Jun 2016
-
-$12.87 M(-1.3%)
-$41.26 M(+33.2%)
Mar 2016
-
-$13.04 M(+176.6%)
-$30.98 M(+50.7%)
Dec 2015
-$20.56 M(+141.4%)
-$4.71 M(-55.7%)
-$20.56 M(+11.5%)
Sep 2015
-
-$10.63 M(+309.9%)
-$18.45 M(+76.2%)
Jun 2015
-
-$2.59 M(-1.1%)
-$10.47 M(+32.9%)
Mar 2015
-
-$2.62 M(+1.0%)
-$7.88 M(+49.9%)
Dec 2014
-$8.52 M(+62.7%)
-$2.60 M(-2.3%)
-$5.25 M(+97.7%)
Sep 2014
-
-$2.66 M
-$2.66 M
Dec 2013
-$5.24 M
-
-

FAQ

  • What is Aclaris Therapeutics annual net profit?
  • What is the all time high annual net income for Aclaris Therapeutics?
  • What is Aclaris Therapeutics annual net income year-on-year change?
  • What is Aclaris Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Aclaris Therapeutics?
  • What is Aclaris Therapeutics quarterly net income year-on-year change?
  • What is Aclaris Therapeutics TTM net profit?
  • What is the all time high TTM net income for Aclaris Therapeutics?
  • What is Aclaris Therapeutics TTM net income year-on-year change?

What is Aclaris Therapeutics annual net profit?

The current annual net income of ACRS is -$88.48 M

What is the all time high annual net income for Aclaris Therapeutics?

Aclaris Therapeutics all-time high annual net profit is -$5.24 M

What is Aclaris Therapeutics annual net income year-on-year change?

Over the past year, ACRS annual net profit has changed by -$1.57 M (-1.81%)

What is Aclaris Therapeutics quarterly net profit?

The current quarterly net income of ACRS is -$7.59 M

What is the all time high quarterly net income for Aclaris Therapeutics?

Aclaris Therapeutics all-time high quarterly net profit is -$1.49 M

What is Aclaris Therapeutics quarterly net income year-on-year change?

Over the past year, ACRS quarterly net profit has changed by +$21.68 M (+74.07%)

What is Aclaris Therapeutics TTM net profit?

The current TTM net income of ACRS is -$37.00 M

What is the all time high TTM net income for Aclaris Therapeutics?

Aclaris Therapeutics all-time high TTM net profit is -$2.66 M

What is Aclaris Therapeutics TTM net income year-on-year change?

Over the past year, ACRS TTM net profit has changed by +$77.62 M (+67.72%)